Summit

The guidance cites "game-changer", alongside "life-changing" and "breakthrough", as phrases that can make media unlawful by exaggerating a medicine's efficacy. Mark Butler has used two of them. For the third, he preferred "ground-breaking".

Hayley Tamborini, Arrotex's Chief Innovation Officer and Head of Government Affairs, called the listing an important step forward for people living with the condition.

In this publication's 14 years, only one organisation has answered questions with responses that its internal documents subsequently revealed reflected a decision to mislead. The TGA has been the only one, and the question concerned advertising. That same agency judges what counts as genuine news and the public interest.

Melbourne cryopreservation company Vitrafy Life Sciences has signed its third partnership with a US civilian blood network. It is the first of the three built around platelets, the fragile blood component whose seven-day shelf life leaves hospitals short of supply.

Paradigm Biopharmaceuticals has entered voluntary administration. The Melbourne drug developer made the move after an interim result halted its Phase 3 trial, and now hopes to restructure its debts while assessing what the trial data can still offer.

The United States Food and Drug Administration has granted Telix Pharmaceuticals Fast Track designation for its BiPASS program. The decision could shorten the path to market for a scan designed to help men avoid prostate biopsies they don't need.

Her story comes as new research commissioned by GSK Australia shows a gap between what Australians know and what they do. Many recognise how much damage shingles can cause, but few prioritise understanding their own risk.

Australia's approach to newborn diagnostic testing seems very confusing. One reason cited in rejecting Pompe was the risk of 'hypervigilant' parents. Pompe is a degenerative condition where early diagnosis and treatment are critical. Yet some state-based research programs are testing for inherited high cholesterol.

More than 24,000 meals will reach families across New South Wales and the ACT this Christmas after staff from Biogen Australia and New Zealand spent a day packing hampers with Foodbank.

The TGA says it "does not seek to restrict genuine public‑interest journalism." Yet it has appointed itself the agency responsible for deciding what meets that test. It is an utter disgrace, and nothing less than a generational assault on free expression.

The 1946 referendum still shapes health policy, driven by long-held beliefs and an abundance of caution. Yet why is the broad application of location rules considered unconstitutional for general practice, but allowed for pharmacies? The explanation is all too simple and reflects a sentence structure with a bracketed short phrase in one place.

The body representing Australia's life sciences workforce says it supports the Government's push to simplify the Research and Development Tax Incentive, but also warns that one planned change could move the regulatory and safety work behind clinical trials out of the country.